Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 407

1.

Update of treatment of heart failure with reduction of left ventricular ejection fraction.

Aronow WS.

Arch Med Sci Atheroscler Dis. 2016 Oct 17;1(1):e106-e116. doi: 10.5114/amsad.2016.63002. eCollection 2016.

2.

The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.

Liao KM, Lin TY, Huang YB, Kuo CC, Chen CY.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 26;12:2573-2581. doi: 10.2147/COPD.S141694. eCollection 2017.

3.

Meta-Analysis Comparing Metoprolol and Carvedilol on Mortality Benefits in Patients With Acute Myocardial Infarction.

Li J, Chen Z, Gao X, Zhang H, Xiong W, Ju J, Xu H.

Am J Cardiol. 2017 Nov 1;120(9):1479-1486. doi: 10.1016/j.amjcard.2017.07.036. Epub 2017 Jul 29.

PMID:
28882337
4.

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F.

Data Brief. 2017 Jul 18;14:197-205. doi: 10.1016/j.dib.2017.07.033. eCollection 2017 Oct.

5.

Calcium/Calmodulin-Dependent Protein Kinase II Activity Persists During Chronic β-Adrenoceptor Blockade in Experimental and Human Heart Failure.

Dewenter M, Neef S, Vettel C, Lämmle S, Beushausen C, Zelarayan LC, Katz S, von der Lieth A, Meyer-Roxlau S, Weber S, Wieland T, Sossalla S, Backs J, Brown JH, Maier LS, El-Armouche A.

Circ Heart Fail. 2017 May;10(5):e003840. doi: 10.1161/CIRCHEARTFAILURE.117.003840.

PMID:
28487342
6.

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.

Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L.

Clin Res Cardiol. 2017 Apr 22. doi: 10.1007/s00392-017-1115-0. [Epub ahead of print]

PMID:
28434020
7.

Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data.

Moskowitz A, Chen KP, Cooper AZ, Chahin A, Ghassemi MM, Celi LA.

Shock. 2017 Oct;48(4):436-440. doi: 10.1097/SHK.0000000000000869.

PMID:
28328711
8.

Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes.

Qi J, Yu J, Tan Y, Chen R, Xu W, Chen Y, Lu J, Liu Q, Wu J, Gu W, Zhang M.

Sci Rep. 2017 Feb 16;7:42843. doi: 10.1038/srep42843.

9.

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.

Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J, Silvola JM, Roivainen A, Saraste A, Nickel AG, Saar JA, Sieve I, Pietzsch S, Müller M, Bogeski I, Kappl R, Jauhiainen M, Thackeray JT, Scherr M, Bengel FM, Hagl C, Tudorache I, Bauersachs J, Maack C, Hilfiker-Kleiner D.

Eur Heart J. 2017 Feb 1;38(5):349-361. doi: 10.1093/eurheartj/ehw086.

10.

Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.

Rosa GM, Meliota G, Brunelli C, Ferrero S.

Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):473-481. doi: 10.1080/17425255.2017.1291631. Epub 2017 Feb 15. Review.

PMID:
28162002
11.

Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.

Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé MP, Rouleau JL, Tardif JC, Jenna S, Haibe-Kains B, Leduc R, Deblois D.

Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):81-90. doi: 10.1002/pds.4132. Epub 2016 Nov 16.

PMID:
27859924
12.

Suppressive Effect of Carvedilol on Na+/Ca2+ Exchange Current in Isolated Guinea-Pig Cardiac Ventricular Myocytes.

Tashiro M, Watanabe Y, Yamakawa T, Yamashita K, Kita S, Iwamoto T, Kimura J.

Pharmacology. 2017;99(1-2):40-47. doi: 10.1159/000450753. Epub 2016 Sep 28.

PMID:
27673688
13.

The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.

Heusch G, Gersh BJ.

Eur Heart J. 2017 Mar 14;38(11):774-784. doi: 10.1093/eurheartj/ehw224.

PMID:
27354052
14.

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients.

Taneva B, Caparoska D.

Open Access Maced J Med Sci. 2016 Mar 15;4(1):94-7. doi: 10.3889/oamjms.2016.022. Epub 2016 Feb 8.

15.

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Bell RM, Bøtker HE, Carr RD, Davidson SM, Downey JM, Dutka DP, Heusch G, Ibanez B, Macallister R, Stoppe C, Ovize M, Redington A, Walker JM, Yellon DM.

Basic Res Cardiol. 2016 Jul;111(4):41. doi: 10.1007/s00395-016-0558-1. Epub 2016 May 10. Review.

16.

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction.

Ozaydin M, Yucel H, Kocyigit S, Adali MK, Aksoy F, Kahraman F, Uysal BA, Erdogan D, Varol E, Dogan A.

Med Princ Pract. 2016;25(4):316-22. doi: 10.1159/000446184. Epub 2016 May 10.

17.

Failure of intravenous lipid emulsion in treatment of cardiotoxicity caused by mixed overdose including dihydropyridine calcium channel blockers.

Jović-Stosić J, Putić V, Zivanović D, Mladenov M, Brajković G, Djordjević S.

Vojnosanit Pregl. 2016 Jan;73(1):88-91.

PMID:
26964391
18.

Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.

Su VY, Chang YS, Hu YW, Hung MH, Ou SM, Lee FY, Chou KT, Yang KY, Perng DW, Chen TJ, Liu CJ.

Medicine (Baltimore). 2016 Feb;95(5):e2427. doi: 10.1097/MD.0000000000002427.

19.

Beta-blockers for congestive heart failure in children.

Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK.

Cochrane Database Syst Rev. 2016 Jan 28;(1):CD007037. doi: 10.1002/14651858.CD007037.pub3. Review.

PMID:
26820557
20.

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Tang CH, Wang CC, Chen TH, Hong CY, Sue YM.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002584. doi: 10.1161/JAHA.115.002584.

Supplemental Content

Loading ...
Support Center